Compare with NUTRAPLUS PR - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs NUTRAPLUS PR - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES NUTRAPLUS PR ZIM LABORATORIES/
NUTRAPLUS PR
 
P/E (TTM) x 39.5 -0.1 - View Chart
P/BV x 1.5 0.3 466.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ZIM LABORATORIES   NUTRAPLUS PR
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
NUTRAPLUS PR
Mar-20
ZIM LABORATORIES/
NUTRAPLUS PR
5-Yr Chart
Click to enlarge
High Rs13122 600.5%   
Low Rs535 986.0%   
Sales per share (Unadj.) Rs189.225.6 738.5%  
Earnings per share (Unadj.) Rs4.5-14.0 -32.1%  
Cash flow per share (Unadj.) Rs14.2-12.7 -112.5%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs99.06.3 1,561.2%  
Shares outstanding (eoy) m16.2434.09 47.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.50.5 91.6%   
Avg P/E ratio x20.5-1.0 -2,106.0%  
P/CF ratio (eoy) x6.5-1.1 -601.4%  
Price / Book Value ratio x0.92.1 43.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,497464 322.2%   
No. of employees `000NANA-   
Total wages/salary Rs m35873 487.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,073873 351.8%  
Other income Rs m231 1,634.3%   
Total revenues Rs m3,096875 353.9%   
Gross profit Rs m346-358 -96.5%  
Depreciation Rs m15847 335.9%   
Interest Rs m10974 146.6%   
Profit before tax Rs m102-478 -21.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m290-   
Profit after tax Rs m73-478 -15.3%  
Gross profit margin %11.3-41.0 -27.4%  
Effective tax rate %28.50-   
Net profit margin %2.4-54.8 -4.3%  
BALANCE SHEET DATA
Current assets Rs m1,918178 1,077.7%   
Current liabilities Rs m1,420890 159.6%   
Net working cap to sales %16.2-81.5 -19.9%  
Current ratio x1.40.2 675.1%  
Inventory Days Days161 2,430.4%  
Debtors Days Days85812 7,422.9%  
Net fixed assets Rs m1,304939 139.0%   
Share capital Rs m162170 95.3%   
"Free" reserves Rs m1,44546 3,162.8%   
Net worth Rs m1,608216 743.7%   
Long term debt Rs m2182 10,700.5%   
Total assets Rs m3,2221,117 288.6%  
Interest coverage x1.9-5.4 -35.7%   
Debt to equity ratio x0.10 1,438.8%  
Sales to assets ratio x1.00.8 121.9%   
Return on assets %5.7-36.2 -15.6%  
Return on equity %4.6-221.3 -2.1%  
Return on capital %11.6-185.1 -6.3%  
Exports to sales %67.41.3 5,231.4%   
Imports to sales %4.10.7 605.1%   
Exports (fob) Rs m2,07211 18,403.9%   
Imports (cif) Rs m1276 2,127.5%   
Fx inflow Rs m2,14011 19,003.1%   
Fx outflow Rs m1276 2,127.5%   
Net fx Rs m2,0125 38,184.3%   
CASH FLOW
From Operations Rs m31991 351.2%  
From Investments Rs m-59-27 219.0%  
From Financial Activity Rs m-260-76 343.3%  
Net Cashflow Rs m-1-12 5.8%  

Share Holding

Indian Promoters % 33.3 40.1 83.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 59.9 111.4%  
Shareholders   3,646 7,943 45.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Zooms 750 Points as IT & Realty Stocks Rally; M&M, ONGC and NTPC Surge 4%(10:30 am)

Asian stock markets recovered some of the losses today sparked by the Federal Reserve's pivot to tighter monetary policy.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022(Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


Jan 28, 2022 11:04 AM

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES - KIMIA BIOSCIENCES COMPARISON

COMPARE ZIM LABORATORIES WITH

MARKET STATS